scispace - formally typeset
G

Guoying Deng

Researcher at Shanghai Jiao Tong University

Publications -  60
Citations -  1258

Guoying Deng is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Photothermal therapy & Chemistry. The author has an hindex of 15, co-authored 46 publications receiving 683 citations. Previous affiliations of Guoying Deng include Nanjing Medical University.

Papers
More filters
Journal ArticleDOI

Tumor environment responsive degradable CuS@mSiO2@MnO2/DOX for MRI guided synergistic chemo-photothermal therapy and chemodynamic therapy

TL;DR: A smart tumor environment responsive theranostic agent based on CuS@mSiO2@MnO2 nanocomposites was fabricated by a facile method and the growth of tumors was greatly inhibited by the synergetic chemo-photothermal therapy and CDT.
Journal ArticleDOI

Se@SiO2–FA–CuS nanocomposites for targeted delivery of DOX and nano selenium in synergistic combination of chemo-photothermal therapy

TL;DR: The Se@SiO2-FA-CuS/DOX nanocomposites have great potential as a multifunctional nanoplatform in future clinical applications because of their excellent targeting ability and synergistic effect of chemotherapy and photothermal therapy.
Journal ArticleDOI

Degradable rhenium trioxide nanocubes with high localized surface plasmon resonance absorbance like gold for photothermal theranostics.

TL;DR: A simple but powerful, safe and biodegradable inorganic theranostic platform to achieve PA/CT/IR imaging-guided cancer photothermal therapy (PTT) for improved therapeutic efficacy and decreased toxic side effects.
Journal ArticleDOI

A novel and facile synthesis of porous SiO2-coated ultrasmall Se particles as a drug delivery nanoplatform for efficient synergistic treatment of cancer cells

TL;DR: A novel and facile synthetic route has been developed to fabricate porous SiO2-coated ultrasmall Se particles (Se@SiO2 nanospheres) as a drug delivery nanoplatform which combines Se quantum dots and doxorubicin for efficient synergistic treatment of cancer cells.
Journal ArticleDOI

Right Cu2−xS@MnS Core–Shell Nanoparticles as a Photo/H2O2-Responsive Platform for Effective Cancer Theranostics

TL;DR: In vivo experiments demonstrate that Cu2 −xS@MnS CSNPs can mediate tumor shrinkage in both HeLa tumor cell line‐derived xenograft and head and neck squamous cell carcinoma models, with the capability of being used as a T1‐enhanced magnetic resonance (MR) contrast agent.